Article: Circassia Announces the Appointment of Sir Richard Sykes as Chairman of the Board.

OXFORD, England, July 4 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on controlling immune system responses, today announced the appointment of Sir Richard Sykes as Chairman of the Board. Sir Richard succeeds Charles Swingland who held the post of Executive Chairman following the establishment of the business earlier this year. Mr Swingland will remain with Circassia as Deputy Chairman and General Counsel.

"We are delighted to welcome Sir Richard to the Board during this period of exciting growth for Circassia," said Charles Swingland, Circassia's Deputy Chairman. "Sir Richard brings an incomparable wealth of experience and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!